Showing results (411-420 of 445) with videos related to

Sort By:
Pageof 45
Journal of Immunology (Baltimore, Md. : 1950)|October 20, 2010
TIM-3: a novel regulatory molecule of alloimmune activationOlaf Boenisch, Francesca D'Addio, Toshihiko Watanabe, et al.
Journal of Research in Medical Sciences : the Official Journal of Isfahan University of Medical Sciences|November 10, 2022
Isfahan COVID cohort study: Rationale, methodology, and initial resultsNizal Sarrafzadegan, Noushin Mohammadifard, Shaghayegh Haghjooy Javanmard, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2007
PDL1 is required for peripheral transplantation tolerance and protection from chronic allograft rejectionKatsunori Tanaka, Monica J Albin, Xueli Yuan, et al.
The Journal of Clinical Investigation|January 4, 2008
The emerging role of T cell Ig mucin 1 in alloimmune responses in an experimental mouse transplant modelTakuya Ueno, Antje Habicht, Michael R Clarkson, et al.
The Oncologist|November 7, 2022
Genomic Profiling Reveals Differences in Primary Central Nervous System Lymphoma and Large B-Cell Lymphoma, With Subtyping Suggesting Sensitivity to BTK InhibitionEric A Severson, James Haberberger, Amanda Hemmerich, et al.
Neuro-Oncology Advances|December 16, 2024
Machine learning prediction of brain metastasis invasion pattern on brain magnetic resonance imaging scansKeyhan Najafian, Benjamin Rehany, Alexander Nowakowski, et al.
ARYA Atherosclerosis|March 19, 2025
Effectiveness and medication adherence in patients with ST- elevated myocardial infarction: Persian polypill studyElaheh Amirfar, Ehsan Shirvani, Shervin Ghaffari Hoseini, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2005
CD70 signaling is critical for CD28-independent CD8+ T cell-mediated alloimmune responses in vivoAkira Yamada, Alan D Salama, Masayuki Sho, et al.
Circulation|July 4, 2019
Notch-1 Inhibition Promotes Immune Regulation in Transplantation Via Regulatory T Cell-Dependent MechanismsCiara N Magee, Naoka Murakami, Thiago J Borges, et al.
Molecular Genetics and Metabolism|December 8, 2022
Venglustat, an orally administered glucosylceramide synthase inhibitor: Assessment over 3 years in adult males with classic Fabry disease in an open-label phase 2 study and its extension studyPatrick B Deegan, Ozlem Goker-Alpan, Tarekegn Geberhiwot, et al.
Pageof 45